A new high-dose chemotherapy regimen has been shown to improve survival of children with high-risk neuroblastoma, a common pediatric cancer, according to a European clinical trial published Sunday.
Donna Vinson suddenly felt she "couldn't think well." She was far off from choosing the right words, even pointing to a garbage can once as she asked a family member to pass the potatoes.
(AP) -- Medical device maker Novocure says it has received U.S. approval for a first-of-a-kind treatment which fights cancerous brain tumors using electrical energy fields.
(PhysOrg.com) -- Research directed by Basar Bilgicer, assistant professor of chemical and biomolecular engineering and a member of the Advanced Diagnostics and Therapeutics initiative at the University of Notre Dame, could ...
Cabernet and chocolate are potent medicine for killing cancer, according to research presented here Wednesday.
(AP) -- Medicare officials said Wednesday that the program will pay the $93,000 cost of prostate cancer drug Provenge, an innovative therapy that gives men suffering from the disease an extra four months to live, on average.
New research shows that a less-toxic combination of a targeted immune-based drug and a chemotherapy drug can produce long-term remissions in some chronic lymphocytic leukemia patients. And it does so without increasing the ...
Researchers at Duke University Medical Center have just completed a clinical trial that showed it is possible to study a new combination of drugs against a melanoma recurrence that has not spread beyond a limb. Using a fairly ...
Mechanical engineering professor Warren Finlay has taken on a major role in research to improve drug delivery for lung cancer patients.
US health authorities have approved a vaccine intended to prevent anal cancer and pre-cancerous lesions in young people aged nine to 26 years old.